Johnson & Johnson subsidiary escapes Canadian probe
Canada’s antitrust authority has dropped its abuse of dominance investigation into Janssen, as it could not prove the pharmaceutical company’s conduct hurt competition in the biosimilar drug market.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.